World-class research. Ultimate impact.
More on impact ›

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Cardiovasc. Med. | doi: 10.3389/fcvm.2019.00125

Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction

 Chiara Borrelli1, 2, 3,  Francesco Gentile1,  Paolo Sciarrone1,  Gianluca Mirizzi1, 2, Giuseppe Vergaro1, 2, Nicolò Ghionzoli1, Francesca Bramanti1, Giovanni Iudice1,  Claudio Passino1, 2, Michele Emdin1, 4 and  Alberto Giannoni1, 2*
  • 1Gabriele Monasterio Tuscany Foundation (CNR), Italy
  • 2Institute of Life Sciences, Sant'Anna School of Advanced Studies, Italy
  • 3University of Pisa, Italy
  • 4Sant'Anna School of Advanced Studies, Italy

Background Although central apneas (CA) and obstructive apneas (OA) are highly prevalent in heart failure (HF), a comparison of apnea prevalence, predictors and clinical correlates in the whole HF spectrum, including HF with reduced ejection fraction (HFrEF), mid-range EF (HFmrEF) and preserved EF (HFpEF) has never been carried out so far.
Materials and methods 700 HF patients were prospectively enrolled and then divided according to left ventricular EF (408 HFrEF, 117 HFmrEF, 175 HFpEF). All patients underwent a thorough evaluation including: 2D echocardiography; 24-hours Holter-ECG monitoring; cardiopulmonary exercise testing; neuro-hormonal assessment and 24-hour cardiorespiratory monitoring.
Results In the whole population, prevalence of normal breathing (NB), CA and OA at daytime was 40%, 51%, and 9%, respectively, while at nighttime 15%, 55%, and 30%, respectively. When stratified according to left ventricular EF, CA prevalence decreased (daytime: 57% vs. 43% vs. 42%, p=0.001; nighttime: 66% vs. 48% vs. 34%, p<0.0001) from HFrEF to HFmrEF and HFpEF, while OA prevalence increased (daytime: 5% vs. 8% vs. 18%, p<0.0001; nighttime 20% vs. 29% vs. 53%, p<0.0001).
In HFrEF, male gender and body mass index (BMI) were independent predictors of both CA and OA at nighttime, while age, New York Heart Association functional class and diastolic dysfunction of daytime CA. In HFmrEF and HFpEF male gender and systolic pulmonary artery pressure were independent predictors of CA at daytime, while hypertension predicted nighttime OA in HFpEF patients; no predictor of nighttime CA was identified.
When compared to patients with NB, those with CA had higher neuro-hormonal activation in all HF subgroups. Moreover, in the HFrEF subgroup, patients with CA were older, more comorbid and with greater hemodynamic impairment while, in the HFmrEF and HFpEF subgroups, they had higher left atrial volumes and more severe diastolic dysfunction, respectively. When compared to patients with NB, those with OA were older and more comorbid independently from background EF.
Conclusions Across the whole spectrum of HF, CA prevalence increases and OA decreases as left ventricular systolic dysfunction progresses. Different predictors and specific clinical characteristics might help to identify patients at risk of developing CA or OA in different HF phenotypes.

Keywords: Heart Failure, Central apneas, Heart failure with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction (HFmrEF), Heart failure with preserved ejection fraction (HFpEF), Obstructive apneas

Received: 31 May 2019; Accepted: 12 Aug 2019.

Edited by:

Filippo M. Sarullo, Ospedale Buccheri la Ferla Fatebenefratelli, Italy

Reviewed by:

Yoshitaka Iwanaga, Kyoto University Hospital, Japan
Kenichi Hongo, Jikei University School of Medicine, Japan  

Copyright: © 2019 Borrelli, Gentile, Sciarrone, Mirizzi, Vergaro, Ghionzoli, Bramanti, Iudice, Passino, Emdin and Giannoni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: MD, PhD. Alberto Giannoni, Gabriele Monasterio Tuscany Foundation (CNR), Pisa, 56124, Tuscany, Italy, alberto.giannoni@gmail.com